Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the nutrition for healthy living cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 4, 2006, Pages 475-482

  Jones, Clara Y ^a   Tang, Alice M ^a   Forrester, Janet E ^a   Huang, Jinyong ^a   Hendricks, Kristy M ^a   Knox, Tamsin A ^a   Spiegelman, Donna ^b   Semba, Richard D ^c   Woods, Margo N ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha tocopherol; CD4 cell count; HIV; Log viral load; Micronutrients; Nutrition for Healthy Living Cohort; Retinol; Selenium; Zinc

Indexed keywords

ALPHA TOCOPHEROL; RETINOL; SELENIUM; TRACE ELEMENT;

ADULT; ARTICLE; BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUTRITION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIROLOGY; VIRUS LOAD; ZINC DEFICIENCY;

ADULT; ALPHA-TOCOPHEROL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIFE STYLE; MALE; MICRONUTRIENTS; MIDDLE AGED; SELENIUM; VIRAL LOAD; VITAMIN A; ZINC;

EID: 33750962015     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000243096.27029.fe     Document Type: Article

References (47)

1. Semba R, Caiaffa W, Graham N, et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis. 1995;171:1196-1202.
2. Semba R, Graham N, Caiaffa W, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993;153:2149-2154.
3. Semba R, Miotti P, Chiphangwi J, et al. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis. 1995;21:966-972.
4. Tang A, Graham N, Semba R, et al. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS. 1997;11:613-620.
5. Baum M, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:370-374.
6. Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr. 1999;20:508-513.
7. Kupka R, Msamanga G, Spiegelman D, et al. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr. 2004;134:2556-2560.
8. Lai H, Lai S, Shor-Posner G, et al. Plasma zinc, copper, copper:zinc ratio, and survival in a cohort of HIV-1-infected homosexual men. J Acquir Immune Defic Syndr. 2001;27:56-62.
9. Fawzi W, Mbise R, Hertzmark E, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999;18:127-133.
10. Burbano X, Miguez-Burbano M, McCollister K, et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials. 2002;3:483-491.
11. Jiamton S, Pepin J, Suttent R, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS. 2003;17:2461-2469.
12. Shor-Posner G, Lecusay R, Miguez M, et al. Psychological burden in the era of HAART: impact of selenium therapy. Int J Psychiatry Med. 2005;33:55-69.
13. Fawzi W, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS. 2002;16:1935-1944.
14. Fawzi W, Msamanga G, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2005;351:23-32.
15. McClelland R, Baeten J, Overbaugh J, et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr. 2004;37:1657-1663.
16. Tang A, Graham N, Kirby A, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol. 1993;138:937-951.
17. Fawzi W, Villamor E, Msamanga G, et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr. 2005;81:161-167.
18. Semba R, Lyles C, Margolick J, et al. Vitamin A supplementation and human immunodeficiency virus load in injection drug users. J Infect Dis. 1998;177:611-616.
19. Coodley G, Coodley M, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS. 1996;10:967-973.
20. Knox T, Spiegelman D, Skinner S, et al. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95:3482-3489.
21. Comstock G, Alberg A, Helzlsouer K. Reported effects of long-term freezer storage on concentrations of retinol, beta-carotene, and alpha-tocopherol in serum or plasma summarized. Clin Chem. 1993;39:1075-1079.
22. Gunter E, Driskell W, Yeager P. Stability of vitamin E in long-term stored serum. Clin Chim Acta. 1988;175:329-336.
23. Hsing A, Comstock G, Polk B. Effect of repeated freezing and thawing on vitamins and hormones in serum. Clin Chem. 1989;35:2145.
24. Sowell A, Huff D, Yeager P, et al. Simultaneous determination of retinal, α-tocopherol, lutein/zeaxanthin, b-cryptoxanthin, lycopene, trans-β-carotene, and four retinyl esters in serum by reverse-phase high performance liquid chromatography with multiwavelength detection. Clin Chem. 1994;40:411-416.
25. Bieri J, Tolliver T, Catignani G. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr. 1979;32:2143-2149.
26. Baum M, Shor-Posner G, Ying L, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9:1051-1056.
27. Siberry G, Ruff A, Black R. Zinc and human immunodeficiency virus infection. Nutr Res. 2002;22:527-538.
28. Bender D, Bender A. Vitamin A and carotenes. In: Nutrition: A Reference Handbook. New York: Oxford University Press; 1997:228-244.
29. Baum M, Campa A, Lai S, et al. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin Infect Dis. 2003;37(Suppl): S117-S123.
30. Baum M, Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev. 1998;56(Suppl):S135-S139.
31. Hendricks K, Dong K, Tang A, et al. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr. 2003;78:790-795.
32. Woods M, Spiegelman D, Knox T, et al. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc. 2002;102:203-211.
33. Schakel S, Sievert Y, Buzzard I. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc. 1988;88:1268-1271.
34. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication No. 98-4083, Bethesda, MD, 1998.
35. Bogden J, Baker H, Frank O, et al. Micronutrient status and human immunodeficiency virus (HIV) infection. Ann NY Acad Sci. 1990;587: 189-195.
36. Beach R, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992;6:701-708.
37. Visser M, Maartens G, Kossew G, et al. Plasma vitamin A and zinc levels in HIV-infected adults in Cape Town, South Africa. Br J Nutr. 2003;89:475-482.
38. Read J, Bethel J, Harris D, et al. Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1 infected children. Ped Infect Dis J. 1999;18:134-142.
39. Rousseau M, Molines C, Moreau J, et al. Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann Nutr Metab. 2000;44:212-216.
40. Tang A, Smit E, Semba R, et al. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;23:321-326.
41. Duggan C, MacLeod W, Krebs N, et al. Plasma zinc concentrations are depressed during the acute phase response in children with Falciparum malaria. J Nutr. 2005;135:802-807.
42. Batterham M, Gold J, Naidoo D, et al. A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr. 2001;55:107-114.
43. Taylor E, Cox A, Zhao L, et al. Nutrition, HIV, and drug abuse: the molecular basis of a unique role for selenium. J Acquir Immune Defic Syndr. 2000;25(Suppl):S53-S61.
44. Vivekananthan D, Penn M, Sapp S, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017-2023.
45. Humphrey J, Quinn T, Fine D, et al. Short-term effects of largedose vitamin A supplementation on viral load and immune response in HIV-infected women. J Acquir Immune Defic Syndr. 1999;20:44-51.
46. MacDonald K, Malonza I, Chen D, et al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS. 2001;15:635-639.
47. Food and Nutrition Board, National Research Council. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and Zinc. Washington, DC: National Academy Press, 2002.